Is warfarin underused in the treatment of elderly persons with atrial fibrillation?

Archives of Internal Medicine

Volumn 157, Issue 4, 1997, Pages 441-445

  Whittle, Jeff ^a,c   Wickenheiser, Leona ^b   Venditti, Laura N ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b Keystone Peer Rev Organization Inc   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; DRUG CONTRAINDICATION; FEMALE; GERIATRIC PATIENT; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICARE; MULTICENTER STUDY; PATIENT SELECTION; PRIORITY JOURNAL; STROKE;

EID: 0031053980     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.4.441     Document Type: Article

References (20)

1. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Arch Intern Med. 1995;155:469-473.
2. Laupacis A, Albers G, Dunn M, Feinberg W. Antithrombotic therapy in atrial fibrillation. Chest. 1992;102:4265-4335.
3. Braunwald E. Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia, Pa: WB Saunders Co; 1992.
4. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (The Cardiovascular Health Study). Am J Cardiol. 1994;74:236-241.
5. Stroke Prevention in Atrial Fibrillation Study Group Investigators. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study. N Engl J Med. 1990;322:863-867.
6. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications of chronic atrial fibrillation: The Copenhagen AFASAK Study. Lancet. 1989;1:175-179.
7. Albers GW, Atwood JE, Hirsh J, Sherman DG, Hughes RA, Connolly SJ. Stroke prevention in nonvalvular atrial fibrillation. Ann Intern Med. 1991;115:727-736.
8. Ezekowitz MD, Bridgers SL, James KE, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation: Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med. 1992;327:1406-1412.
9. Laupacis A, Albers G, Dalen J, Dunn M, Feinberg W, Jacobson A. Antithrombotic therapy in atrial fibrillation. Chest. 1995;108:3525-3595.
10. Lok NS, Lau CP. Presentation and management of patients admitted with atrial fibrillation: a review of 291 cases in a regional hospital. Int J Cancer. 1995;48:271-278.
11. Lip GYH, Tean KN, Dunn FG. Treatment of atrial fibrillation in a distinct general hospital. Br Heart J. 1994;71:92-95.
12. Bath PMW, Prasad A, Brown MM, MacGregor GA. Survey of use of anticoagulation in patients with atrial fibrillation. BMJ. 1993;307:1045.
13. Chang HJ, Bell JR, Deroo DB, Kirk JW, Wasson JH. Physician variation in anticoagulating patients with atrial fibrillation. Arch Intern Med. 1990;150:81-84.
14. McCrory DC, Matchar DB, Samsa G, Sanders LL, Pritchett ELC. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med. 1995;155:277-281.
15. Kahn HA. An Introduction to Epidemiologic Methods. New York, NY: Oxford University Press Inc; 1983.
16. SAS Institute Inc. SAS Language and Procedures: Usage, Version 6. Cary, NC: SAS Institute Inc; 1989.
17. Tversky A, Kahneman D. Judgement under uncertainty: heuristics and biases. Science. 1974;185:1124-1131.
18. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation, I: clinical features of patients at risk. Ann Intern Med. 1992;116:1-5.
19. Chassin MR, Kosecoff J, Park RE, et al. Does inappropriate use explain geographic variations in the use of health care services? a study of three procedures. JAMA. 1987;258:2533-2537.
20. Levine M, Raskob G, Landefeld S, Hirsh J. Hemorrhagic complications of anticoagulant treatment. Chest. 1995;108:276S-290S.